MedSure Systems New Medication Adherence Technology Launches After Successful Patient Trial
Patients Highlight Easy-to-Use Automatic System that Makes Managing and Taking Medications Simple
DALLAS, TX, UNITED STATES, October 23, 2024
MedSure Systems, an emerging leader in the MedTech industry, announces the launch of its new medication adherence technology after impressive first round trial results. Patients using the MedSure System successfully reached a 99.9% medication adherence rate which is considered remarkable against the national average of less than 50%.
“MedSure Systems is at the forefront of solving the medication adherence problem, ensuring that medications are taken exactly as prescribed”
– Justin Monger
Medication adherence, or the consistency with which patients follow their prescribed medication routines, is a significant challenge costing more than $300 billion in healthcare expenses and reportedly more than 125,000 premature deaths annually in America. With more than 41 million Americans aged 65 and older managing multiple chronic diseases, and with 75 million Americans over or underdosing their medications annually, medication adherence is more critical than ever.